Sign Up
|
Sign In
Home
US Market
UK Market
News
My Portfolio
Forex
Forum
Cockpit
EuroTrader
Home
»
World
»
North America
»
United States
»
Biotechnology
»
Amgen Inc
Amgen Inc
AMGN
(NASDAQ)
Overview
Discussions
Advanced chart
News
Historical data
Recommendations
To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.
Industry
:
Health Care
Sector
:
Pharmaceuticals & Biotechnology
$
69.32
Updated
00:30:13
Change %
0.3%
Change
0.1700
Volume
4,248,885
High
$
69.51
Low
$
69.05
Open
$ 69.11
Prev close
$ 69.15
# of shares
-
Market cap
-
Intraday
Market closed
Tech analysis
Market is closed, opens at 14:30
Price development
Latest
1 week
1 month
3 mon
6 mon
1 year
69.32
-1.9%
1.2%
3.8%
24.5%
13.9%
Insufficient flash player version
News about Amgen Inc
Subscribe To RSS Feed
Local
International
Announcements
10 May
UPDATE: Companies Pour Into High-Grade Corporate Bond Market
10 May
Amgen Sells $3 Billion In US Bond Market
04 May
House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg
01 May
3rd UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales
01 May
2nd UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales
01 May
CORRECT: UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales
01 May
UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales
27 April
WSJ BLOG/Health: A.M. Vitals: U.S. Officials Defend Testing Regime for Mad Cow Disease
27 April
Amgen: FDA Letter Rejects Expanded Use Of Xgeva For Prostate Cancer
25 April
Amgen To Buy Mustafa Nevzat For $700 Million
23 March
Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment Wi
23 March
Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alend
22 March
ITG's Majestic Market Research Prostate Cancer Study Indicates Amgen's Xgeva is Poised to Steal Significant Share From Novartis'
21 March
Critical Alerts For ConocoPhillips, Amgen, NYSE Euronext, NetApp, and Foot Locker Released By Seven Summits Research
18 March
Amgen Statement on CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
04 February
Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis
24 January
Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass
24 January
Amgen's Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Shar
24 January
Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results
18 January
Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
No news for this instrument
More news
Company profile
No description
Version: LiveBranchBuild_20120516.1 - EUROWEB1 - 2012-05-22 02:07:18 - 2012-05-22 01:07:18 - 1000 - Website: OKAY